LipoPeptide Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

LipoPeptide General Information

Description

Developer of biopharmaceutical products for wound care. The company develops lipopeptide-based products for the treatment of wounds, including chronic, non-healing ulcers in skin and mucous membranes.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Karolinska Institutet Science Park
  • Fogdevreten 2a
  • 171 65 Solna
  • Sweden
+46 08-524
Primary Industry
Pharmaceuticals
Acquirer
Vertical(s)
Corporate Office
  • Karolinska Institutet Science Park
  • Fogdevreten 2a
  • 171 65 Solna
  • Sweden
+46 08-524

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

LipoPeptide Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 31-Dec-2010 Completed Startup
2. Merger/Acquisition Completed Startup
1. Early Stage VC Completed Startup
To view LipoPeptide’s complete valuation and funding history, request access »

LipoPeptide Patents

LipoPeptide Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2015075406-A1 New treatment of chronic ulcers Inactive 19-Nov-2013
WO-2015075441-A1 New treatment of chronic ulcers Inactive 19-Nov-2013
AU-2008269575-A1 New medical products Inactive 25-Jun-2007
CA-2691645-A1 New medical products Inactive 25-Jun-2007
EP-2173389-A2 New medical products Inactive 25-Jun-2007 A61L15/32
To view LipoPeptide’s complete patent history, request access »

LipoPeptide Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Granitor Venture Capital Minority
To view LipoPeptide’s complete investors history, request access »

LipoPeptide FAQs

  • Where is LipoPeptide headquartered?

    LipoPeptide is headquartered in Solna, Sweden.

  • What industry is LipoPeptide in?

    LipoPeptide’s primary industry is Pharmaceuticals.

  • Is LipoPeptide a private or public company?

    LipoPeptide is a Private company.

  • What is LipoPeptide’s current revenue?

    The current revenue for LipoPeptide is .

  • Who are LipoPeptide’s investors?

    Granitor has invested in LipoPeptide.

  • When was LipoPeptide acquired?

    LipoPeptide was acquired on 31-Dec-2010.

  • Who acquired LipoPeptide?

    LipoPeptide was acquired by Pharmasurgics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process